Health Care·Life Sciences Tools & Services·$174.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.84 | N/A | +3.25% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.84 | N/A | +3.25% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting their commitment to customer value. However, they did not provide specific guidance for future quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on delivering value to our customers.
Thermo Fisher Scientific's earnings report shows a positive surprise in EPS, which contributed to a 2.63% increase in the stock price. The company did not provide revenue figures or future guidance, leaving investors to focus on the strong EPS performance. Overall, the market reacted favorably, reflecting confidence in the company's current operations.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
HALLIBURTON CO
Jul 20, 2015